Nanjing Pharmaceutical Group Company Limited (SHSE: 600713)
Health Care · Health Care Providers & Services · CN
CN¥5.00
+1.63% today · +0.8% 1Y
Nanjing Pharmaceutical Group Company Limited (SHSE: 600713) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $975.11M and employs 4,697 people.
Over the last twelve months the share price has gained 0.8%, trading between 4.81 and 6.65.
Tweenvest scores Nanjing Pharmaceutical Group Company Limited across four factors: quality 72/100, value 47/100, growth 40/100, dividend 87/100. Its strongest factor is dividend.
600713 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $975.11M
- Revenue (TTM)
- $8.07B
- P/E
- 11.74
- EPS
- 0.43
- Dividend yield
- 3.60%
- Beta (5Y)
- 0.20
- 52-week high
- CN¥6.65
- 52-week low
- CN¥4.81
- Avg volume (3M)
- —
- Shares outstanding
- 1.31B
- Employees
- 4,697
- Next earnings
- —
About Nanjing Pharmaceutical Group Company Limited
Established in 1951 and headquartered in Nanjing, China, NanJing Pharmaceutical Company Limited specializes in the nationwide wholesale and retail distribution of pharmaceutical products. The company oversees a substantial network comprising approximately 510 physical pharmacy outlets, alongside an active e-commerce platform for online sales.
- ISIN
- CNE000000KV1
- Founded
- 1951
- Listed since
- Jul 1, 1996
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Specialized Medical CompanySASE: 4019 | $992.81M | SR14.91 | -5.69% |
| Clínica Baviera, S.A.BME: CBAV | $987.48M | €55.00 | -1.43% |
| Akso Health GroupNasdaqCM: AHG | $985.21M | $1.14 | -0.87% |
| Summerset Group Holdings LimitedNZSE: SUM | $984.84M | NZ$7.20 | -6.25% |
| Al Hammadi Holding CompanySASE: 4007 | $956.72M | SR22.45 | -1.49% |
| Selçuk Ecza Deposu Ticaret ve Sanayi A.S.IBSE: SELEC | $948.35M | TL75.05 | -40.44% |
| Diagnósticos da América S.A.BOVESPA: DASA3 | $943.13M | R$3.95 | +6.76% |
| Regis Healthcare LimitedASX: REG | $931.27M | AU$4.43 | -0.67% |
Figures last refreshed Oct 4, 2026.